← back to search

Pradipta Ghosh

UC San Diego Health System · US
Area of research
Molecular Biology · Immunology and Allergy
Research interest
Research interests include Protein Kinase Regulation and GTPase Signaling, Receptor Mechanisms and Signaling, Cell Adhesion Molecules Research, and Cellular transport and secretion.
h-index
50
citations
8,024
works
269
NIH funding
primary concept
email

Recent publications

MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)
EBioMedicine 2024cited by 37position: middledoi
A living organoid biobank of patients with Crohn’s disease reveals molecular subtypes for personalized therapeutics
Cell Reports Medicine 2024cited by 21position: lastdoi
Macrophage states: there's a method in the madness
Trends in Immunology 2023cited by 39position: lastdoi
Machine learning identifies signatures of macrophage reactivity and tolerance that predict disease outcomes
EBioMedicine 2023cited by 35position: firstdoi
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects
Journal of Clinical Investigation 2023cited by 31position: middledoi
An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease
Nature Communications 2022cited by 82position: firstdoi
Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with <i>in vitro</i> antitumor activity towards non-small lung cancer
Journal of Enzyme Inhibition and Medicinal Chemistry 2022cited by 73position: middledoi
New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I&amp; II and tubulin polymerization
Journal of Enzyme Inhibition and Medicinal Chemistry 2022cited by 64position: middledoi
COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis
EBioMedicine 2022cited by 42position: lastdoi
Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer
European Journal of Medicinal Chemistry 2022cited by 33position: middledoi
The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients
Cellular and Molecular Gastroenterology and Hepatology 2022cited by 30position: middledoi
Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer
Oncogene 2022cited by 30position: middledoi
Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19
eLife 2021cited by 133position: middledoi
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
Nature Communications 2021cited by 128position: middledoi
Parsing the Role of PPARs in Macrophage Processes
Frontiers in Immunology 2021cited by 102position: middledoi
E-cigarettes compromise the gut barrier and trigger inflammation
iScience 2021cited by 81position: middledoi
Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease
Nature Communications 2021cited by 81position: lastdoi
AI-guided discovery of the invariant host response to viral pandemics
EBioMedicine 2021cited by 54position: lastdoi
Immunosuppression of Macrophages Underlies the Cardioprotective Effects of CST (Catestatin)
Hypertension 2021cited by 53position: middledoi
2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights
Journal of Enzyme Inhibition and Medicinal Chemistry 2021cited by 41position: middledoi
Chromogranin A regulates gut permeability <i>via</i> the antagonistic actions of its proteolytic peptides
Acta Physiologica 2021cited by 35position: middledoi
TLR4 signaling and macrophage inflammatory responses are dampened by GIV/Girdin
Proceedings of the National Academy of Sciences 2020cited by 104position: lastdoi
Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer
Breast Cancer Research 2020cited by 80position: middledoi
Helicobacter pylori infection downregulates the DNA glycosylase NEIL2, resulting in increased genome damage and inflammation in gastric epithelial cells
Journal of Biological Chemistry 2020cited by 64position: middledoi
Host engulfment pathway controls inflammation in inflammatory bowel disease
FEBS Journal 2020cited by 61position: middledoi
Receptor tyrosine kinases activate heterotrimeric G proteins via phosphorylation within the interdomain cleft of Gαi
Proceedings of the National Academy of Sciences 2020cited by 35position: lastdoi
Near-Infrared Light-Activated DNA-Agonist Nanodevice for Nongenetically and Remotely Controlled Cellular Signaling and Behaviors in Live Animals
Nano Letters 2019cited by 99position: middledoi
Erythrocyte sialoglycoproteins engage Siglec-9 on neutrophils to suppress activation
Blood 2017cited by 105position: middledoi
The Alzheimer's disease–protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool
Journal of Biological Chemistry 2017cited by 78position: middledoi
GIV/Girdin activates Gαi and inhibits Gαs via the same motif
Proceedings of the National Academy of Sciences 2016cited by 45position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Soumita Das · University of Massachusetts Lowell13 papers (2020–2024)Gajanan D. Katkar · University of California San Diego12 papers (2020–2024)Debashis Sahoo · University of California San Diego12 papers (2020–2024)Mikel Garcia‐Marcos · Boston University6 papers (2012–2020)Ibrahim M. Sayed · System Biosciences (United States)5 papers (2020–2024)Marilyn G. Farquhar · University of California San Diego5 papers (2012–2016)Inmaculada López-Sánchez · University of California San Diego5 papers (2014–2020)Courtney Tindle · University of California San Diego5 papers (2021–2024)Stella‐Rita Ibeawuchi · University of San Diego5 papers (2020–2024)Sahar Taheri · Shiraz University4 papers (2021–2024)Vanessa Castillo · University of California San Diego4 papers (2020–2022)Mackenzie Fuller · Rocky Mountain MS Center4 papers (2021–2024)Amer Ali Abd El‐Hafeez · Stanford Medicine4 papers (2021–2022)Ayden G. Fonseca · University of California San Diego4 papers (2021–2024)Nicolas Aznar · Université Claude Bernard Lyon 14 papers (2015–2020)Rama F. Pranadinata · University of California San Diego4 papers (2020–2024)Ying Dunkel · University of California San Diego4 papers (2012–2020)Fiona Murray · Massachusetts Institute of Technology3 papers (2014–2020)William J. Sandborn · Mirati Therapeutics (United States)3 papers (2020–2024)Jason Ear · California State Polytechnic University3 papers (2016–2024)